These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28823949)

  • 1. Glucocorticoids and β
    Papakonstantinou E; Klagas I; Karakiulakis G; Tamm M; Roth M; Stolz D
    Pulm Pharmacol Ther; 2018 Feb; 48():104-110. PubMed ID: 28823949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroids and β2-agonists regulate hyaluronan metabolism in asthmatic airway smooth muscle cells.
    Papakonstantinou E; Klagas I; Karakiulakis G; Hostettler K; S'ng CT; Kotoula V; Savic S; Tamm M; Roth M
    Am J Respir Cell Mol Biol; 2012 Dec; 47(6):759-67. PubMed ID: 22865625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPD Exacerbations Are Associated With Proinflammatory Degradation of Hyaluronic Acid.
    Papakonstantinou E; Roth M; Klagas I; Karakiulakis G; Tamm M; Stolz D
    Chest; 2015 Dec; 148(6):1497-1507. PubMed ID: 26226411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
    Latorre M; Novelli F; Vagaggini B; Braido F; Papi A; Sanduzzi A; Santus P; Scichilone N; Paggiaro P
    Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Long-Acting Beta
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
    Petite SE
    Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Tiotropium in Reducing Exacerbations of Chronic Obstructive Pulmonary Disease When Combined With Long-Acting β
    Ferroni E; Belleudi V; Cascini S; Di Martino M; Kirchmayer U; Pistelli R; Patorno E; Formoso G; Fusco D; Perucci CA; Davoli M; Agabiti N;
    J Clin Pharmacol; 2016 Nov; 56(11):1423-1432. PubMed ID: 27095425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
    Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Ann Pharmacother; 2017 Nov; 51(11):945-953. PubMed ID: 28677404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease.
    D'Urzo A; Donohue JF; Kardos P; Miravitlles M; Price D
    Expert Opin Pharmacother; 2015; 16(12):1845-60. PubMed ID: 26194213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment.
    Zarowitz BJ; O'Shea T
    J Manag Care Pharm; 2012 Oct; 18(8):598-606. PubMed ID: 23127147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S; Evans DJ; Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose- and time-dependent effects of hyaluronidase on structural cells and the extracellular matrix of the skin.
    Buhren BA; Schrumpf H; Gorges K; Reiners O; Bölke E; Fischer JW; Homey B; Gerber PA
    Eur J Med Res; 2020 Nov; 25(1):60. PubMed ID: 33228813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of hyaluronic acid are associated with COPD severity and predict survival.
    Papakonstantinou E; Bonovolias I; Roth M; Tamm M; Schumann D; Baty F; Louis R; Milenkovic B; Boersma W; Stieltjes B; Kostikas K; Blasi F; Aerts JG; Rohde GGU; Lacoma A; Torres A; Welte T; Stolz D
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30705130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
    Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Thach C; Patalano F; Banerji D;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1015-26. PubMed ID: 26082625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study.
    Jones R; Martin J; Thomas V; Skinner D; Marshall J; Stagno d'Alcontres M; Price D
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2445-2454. PubMed ID: 28860739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased hyaluronan in airway smooth muscle cells from patients with asthma and COPD.
    Klagas I; Goulet S; Karakiulakis G; Zhong J; Baraket M; Black JL; Papakonstantinou E; Roth M
    Eur Respir J; 2009 Sep; 34(3):616-28. PubMed ID: 19282346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.